FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Pillar Invest Corp		 2. Date of Event Requiring Statement (MM/DD/YYYY)
5/16/2023 

 3. Issuer Name and Ticker or Trading Symbol

Aceragen, Inc. [ACGN]
(Last)        (First)        (Middle)

C/O STUARTS CORPORATE SERVICES LTD., KENSINGTON HOUSE, 69 DR. ROY'S DRIVE		 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)
(Street)

GEORGETOWN, GRAND CAYMAN, E9 KY1-1104      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 355247 I By Pillar Partners Foundation, L.P. (1)
Common Stock 135540 I By Pillar Pharmaceuticals 6, L.P (1)
Common Stock 170712 I By Abude Umari (1)
Common Stock 1547 I By Youssef El Zein (1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrants 7/13/2020 7/13/2023 Common Stock 162601 (2)$0.01 I By Pillar Partners Foundation, L.P. (1)
Warrants 12/11/2020 12/11/2023 Common Stock 35687 (2)$0.01 I By Pillar Partners Foundation, L.P. (1)
Warrants 12/11/2020 12/11/2023 Common Stock 45114 (2)$0.01 I By Pillar Pharmaceuticals 6, L.P. (1)
Explanation of Responses:
(1) Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
(2) The warrants are exercisable subject to a beneficial ownership blocker provision that prevents the holder from exercising the warrants if such exercise would result in the holder beneficially owning more than 19.99% of the Issuer's Common Stock outstanding following such exercise.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Pillar Invest Corp
C/O STUARTS CORPORATE SERVICES LTD.
KENSINGTON HOUSE, 69 DR. ROY'S DRIVE
GEORGETOWN, GRAND CAYMAN, E9 KY1-1104
X

Pillar Partners Foundation, L.P.
C/O STUARTS CORPORATE SERVICES LTD.
KENSINGTON HOUSE, 69 DR. ROY'S DRIVE
GEORGETOWN, GRAND CAYMAN, E9 KY1-1104
X

Pillar Pharmaceuticals 6, L.P.
C/O STUARTS CORPORATE SERVICES LTD.
KENSINGTON HOUSE, 69 DR. ROY'S DRIVE
GEORGETOWN, GRAND CAYMAN, E9 KY1-1104
X

Umari Abude
C/O STUARTS CORPORATE SERVICES LTD.
KENSINGTON HOUSE, 69 DR. ROY'S DRIVE
GEORGETOWN, GRAND CAYMAN, E9 KY1-1104
X

ZEIN YOUSSEF EL
C/O STUARTS CORPORATE SERVICES LTD.
KENSINGTON HOUSE, 69 DR. ROY'S DRIVE
GEORGETOWN, GRAND CAYMAN, E9 KY1-1104
X
Signatures
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person6/23/2023
**Signature of Reporting PersonDate

Pillar Partners Foundation, L.P., /s/ Youssef El Zein, Authorized Person6/23/2023
**Signature of Reporting PersonDate

Pillar Pharmaceuticals, 6, L.P., /s/ Youssef El Zein, Authorized Person6/23/2023
**Signature of Reporting PersonDate

/s/ Abude Umari6/23/2023
**Signature of Reporting PersonDate

/s/ Youssef El Zein6/23/2023
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Idera Pharmaceuticals (NASDAQ:IDRA)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse Idera Pharmaceuticals
Idera Pharmaceuticals (NASDAQ:IDRA)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse Idera Pharmaceuticals